Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 71 entries
View as:

Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01889420 Org: User:
Start: 07/31/14 End: 07/31/15 Due: 07/31/16

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

Phase: N/A Priority: Normal
NCT ID: NCT00832520 Org: User:
Start: 11/30/08 End: 06/30/11 Due: 06/30/12

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02720601 Org: User:
Start: 11/30/15 End: 03/31/20 Due: 03/31/21

Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting

Phase: N/A Priority: Normal
NCT ID: NCT00250744 Org: User:
Start: 12/31/04 End: 09/30/07 Due: 09/30/08

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

Phase: N/A Priority: Normal
NCT ID: NCT06207864 Org: User:
Start: 03/22/22 End: 12/31/30 Due: 12/31/31

Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT00996346 Org: User:
Start: 10/31/09 End: 11/30/13 Due: 11/30/14

Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00871169 Org: User:
Start: 10/31/08 End: 04/30/15 Due: 04/30/16

Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02147418 Org: User:
Start: 02/25/15 End: 07/25/24 Due: 07/25/25

Expanded Breast Cancer Registry and Tissue Repository

Phase: N/A Priority: Normal
NCT ID: NCT00322894 Org: User:
Start: 02/16/06 End: 03/31/25 Due: 03/31/26

Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01100242 Org: User:
Start: 04/30/10 End: 02/28/15 Due: 02/28/16

Combination Paclitaxel, Carboplatin and Temozolomide

Phase: N/A Priority: Normal
NCT ID: NCT00249964 Org: User:
Start: 11/30/03 End: 03/31/11 Due: 03/31/12

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01670799 Org: User:
Start: 03/31/12 End: 12/31/15 Due: 12/31/16

Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00996060 Org: User:
Start: 07/31/08 End: 01/31/13 Due: 01/31/14

Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01806350 Org: User:
Start: 11/30/09 End: 09/30/12 Due: 09/30/13

Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00809458 Org: User:
Start: 09/30/08 End: 02/28/13 Due: 02/28/14

A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

Phase: N/A Priority: Normal
NCT ID: NCT01011998 Org: User:
Start: 09/30/09 End: 07/31/10 Due: 07/31/11

Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

Phase: N/A Priority: Normal
NCT ID: NCT00323726 Org: User:
Start: 12/31/05 End: 12/31/06 Due: 12/31/07

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01478308 Org: User:
Start: 06/30/11 End: 10/31/11 Due: 10/31/12

Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT01275183 Org: User:
Start: 12/31/10 End: 04/30/15 Due: 04/30/16

IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01746810 Org: User:
Start: 07/31/12 End: 10/13/15 Due: 10/13/16

Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study

Phase: N/A Priority: Normal
NCT ID: NCT00322790 Org: User:
Start: 01/31/06 End: 09/30/13 Due: 09/30/14

Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses

Phase: N/A Priority: Normal
NCT ID: NCT02580981 Org: User:
Start: 07/28/16 End: 10/20/22 Due: 10/20/23

Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00250835 Org: User:
Start: 04/30/05 End: 05/31/15 Due: 05/31/16

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00659269 Org: User:
Start: 07/31/06 End: 06/30/15 Due: 06/30/16

Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT01030757 Org: User:
Start: 06/30/09 End: 05/31/13 Due: 05/31/14